Democratizing patient data and/or targets to drive more diverse therapeutics in the pipeline

Suggested by KS Kathy Sennott almost 3 years ago

In the highly regulated landscape of Biotech and Healthtech, patient data must comply with strict regulations like HIPAA and other regulatory rules.

When it comes to target therapies, for-profit companies often have intellectual property protections that prevent the sharing of proprietary research data. This is because many of these companies are competing to be the first to bring therapeutics to the market.

We are currently witnessing a life science revolution, where advancements in AI and technology are making it easier for researchers and scientists to expedite the development of therapeutic drugs. However, many biotech companies tend to guard their intelligence closely. Is there a way to democratize this knowledge, ensuring patient populations and target therapeutics can benefit from it while maintaining anonymity, all in compliance with Web3 standards? Can the use of Blockchain help solve this? Thoughts?